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Abstract An antifungal peptide from leaves of Ginkgo biloba,
designated GAFP, has been isolated. Its molecular mass of
4244.0 Da was determined by mass spectrometry. The complete
amino acid sequence was obtained from automated Edman
degradation. GAFP exhibited antifungal activity towards
Pellicularia sasakii Ito, Alternaria alternata (Fries) Keissler,
Fusarium graminearum Schw. and Fusarium moniliforme. Its
activities differed among various fungi. GAFP could also cause
increased hyphal membrane permeabilization and a rapid
alkalization of the medium when applied at 100 Wg/ml to
Pellicularia sasakii Ito hyphae. The amino acid sequence of
GAFP shows characteristics of the cysteine/glycine-rich chitin
binding domain of many chitin binding proteins. The cysteine
residues are well conserved. ß 2000 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Plants use a variety of cysteine/glycine-rich small antimicro-
bial proteins to protect themselves from pathogen invasion.
Thionines [1^3], plant defensins [4^6], antimicrobial peptides
from Amaranthus caudatus (Ac-AMPs) [7,8], hevein-like [8^10]
and knottin-like peptides [11] belong to these classes of anti-
microbial proteins. They are all small (29^54 residues) and
cysteine-rich peptides, but they are highly divergent in pri-
mary structure and exhibit quite di¡erent antimicrobial activ-
ities. Among them, hevein-like peptides and Ac-AMPs are
also chitin binding peptides. They contain either a hevein
domain or a homologous sequence.
At present, it is not known how most antimicrobial peptides
exhibit antifungal properties and/or antibacterial activities at
the molecular level. Van Parijs et al. [9] speculated that the
antifungal properties of hevein and Urtica dioica agglutinin
are somewhat related to the size of protein molecules. These
proteins are small enough to penetrate through the fungal cell
wall and to reach the plasma membrane, where they may have
an e¡ect on active sites of cell wall morphogenesis. Thionines
are believed to make pores in the membranes, which then
results in leakage of the membrane and leads to the death
of the microorganism [2].
This paper reports the isolation, structural determination,
and the mode of action of a novel antifungal peptide (GAFP)
from leaves of Ginkgo biloba.
2. Materials and methods
2.1. Materials
The leaves of G. biloba were obtained from the garden of our in-
stitute in September. All plant pathogens, including Pellicularia sasa-
kii Ito, Alternaria alternata (Fries) Keissler, Fusarium graminearum
Schw., Fusarium moniliforme and Phytophthora boehmeriae, were pro-
vided by the Jiangsu Institute of Agriculture. Regenerated chitin was
freshly prepared from 3.5 g of chitosan according to the procedure of
Molano et al. [12], autoclaved, equilibrated with 20 mM NaHCO3,
and ¢lled in a chromatography column (2.6 cm in diameter). The
resulting bed volume was about 46 ml. The other reagents were of
the highest grade commercially available.
2.2. Puri¢cation of antifungal peptide
Unless otherwise stated, all puri¢cation steps were carried out at
4‡C. The leaves of G. biloba were fully homogenized with 2^3 volumes
of 30 mM NaPi^citrate bu¡er, pH 5.0 (1 mM phenylmethylsulfonyl
£uoride). The homogenate was ¢ltered on three layers of gauze and
the ¢ltrate was centrifuged at 10 000Ug for 30 min. Solid ammonium
sulfate was added to the supernatant to 80% saturation. After stirring
overnight, the crude proteins were collected by centrifugation
(38 000Ug, 30 min), resuspended in 30 ml of 20 mM NaHCO3 and
dialyzed extensively against 20 mM NaHCO3, with a 3.5 kDa dialysis
membrane. The dialyzed solution was then loaded on the regenerated
chitin column at a £ow rate of 0.5 ml/min. The ¢rst washing was
performed with 20 mM NaHCO3 until the eluate was free of proteins.
A second washing with 20 mM sodium acetate^acetic acid bu¡er, pH
5.6, followed for 90 min. Finally the proteins were released from the
chitin matrix with 20 mM acetic acid, pH 3.3, and immediately dia-
lyzed against distilled water, with a 3.5 kDa dialysis membrane. After
dialysis, the protein solution was dried in a vacuum concentrator.
Then the samples were dissolved in 200 mM NaHCO3 and subjected
to FPLC (Pharmacia Biotech FPLC system) on a Superose 12 column
(Pharmacia Biotech) equilibrated with 200 mM NaHCO3. The sam-
ples were eluted with 200 mM NaHCO3 at a £ow rate of 0.4 ml/min
within 70 min. The eluate was monitored for protein by measurement
of the absorbance at 280 nm. The molecular mass of each fraction was
determined by SDS^PAGE [13]. Antifungal activity was also moni-
tored in each fraction. One active fraction which eluted at 19 min was
then loaded on a reverse-phase C18 column (ABI) in equilibrium with
0.1% tri£uoroacetic acid (TFA) for further puri¢cation. The column
was eluted at 1 ml/min with the following gradient (solvent B is
acetonitrile containing 0.1% TFA): 0^50 min, 0^50% B. The eluate
was monitored for protein by measurement of the absorbance at
214 nm. Chromatography was performed on a HP 1090 HPLC sta-
tion.
2.3. Mass spectrometry analysis
Mass spectrometry analysis of peptides was performed on a Finni-
gan LCQ-MS, an instrument that essentially consists of an atmos-
pheric pressure electrospray positive ion source, attached to a triple
quadrupole mass analyzer. The puri¢ed peptide (100 pmol) was dis-
solved in water/methanol (50:50, v/v) containing 1% (v/v) acetic acid
at a peptide concentration of 5 Wmol/l, and then applied on the MS
instrument.
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2.4. Protein concentration determination and amino acid sequencing
Protein concentration was determined by the method of Bradford
[14], with bovine serum albumin as the standard.
After the puri¢ed peptide was reduced and alkylated according to
the method described by Fullmer [15], automated Edman degradation
of the pyridylethylated peptide and detection of phenylthiohydantoin
derivatives were performed on a pulse liquid automatic sequenator
(Applied Biosystems model 491). The amino acid sequence of residues
was obtained from N-terminal sequencing.
2.5. Assay of antifungal activity
Antifungal activity was determined under sterile condition using a
hyphal extension^inhibition assay as described by Roberts and Seli-
trenniko¡ [16]. Fungal mycelia were harvested from actively growing
fungal plates and placed in the center of Petri dishes containing po-
tato dextrose agar used for maintenance of the fungus under test.
After incubation of these dishes for 48 h at 28‡C to allow for mycelial
growth, sterile ¢lter paper disks were placed on the agar surface in
front of the advancing fungal mycelium and then 20 Wl of the protein
solution in 10 mM sodium acetate bu¡er, pH 5.4, was applied to each
disk. The plates were incubated at 28‡C for 24 h and then photo-
graphed. In this manner, if the material being tested was antifungal, a
crescent-shaped zone of inhibition was observed around the disk.
Percent growth inhibition was assayed as described by Broekaert et
al. [7]. Brie£y, fungal spores or hyphal pieces were collected as de-
scribed by Duvick et al. [17] and standard methods [18]. 90 Wl of PD
liquid medium containing fungal spores or hyphal pieces was incu-
bated for 24 h. After this period, 10 Wl aliquots of various concen-
trations of peptide were added. Growth was recorded after 48 h of
further incubation at 28‡C. The absorption at 595 nm served as a
measure for fungal growth [5].
2.6. Hyphal membrane permeabilization assay and external pH
measurements
P. sasakii Ito was grown at an inoculum density of 3U105 spores/
ml at 28‡C in PD liquid medium. After 30 h of incubation,
[14C]leucine (2 WCi/ml) was added. After an additional incubation of
3 h to allow loading of the hyphae with [14C]leucine, 250 Wl samples
were taken and transferred to 0.5 ml Eppendorf tubes. The samples
were centrifuged at 3000Ug for 5 min at 20‡C. After the supernatant
was discarded, hyphae were washed three times with PD liquid me-
dium. The washed hyphae were then resuspended in 250 Wl of PD
liquid medium containing antifungal proteins (control suspension con-
tained no antifungal protein). After 3 h of incubation in the presence
of the protein, mycelial suspensions were centrifuged at 5000Ug for
5 min at 20‡C, and supernatants were collected into a 96 well micro-
titer plate and counted for 14C.
Mycelial suspensions of P. sasakii Ito, 24 h old, grown in PD liquid
medium at an inoculum density of 3U105 spores/ml, were centrifuged
at 3000Ug for 5 min at 20‡C and resuspended after centrifugation in
PD liquid medium containing 100 Wg/ml antifungal protein. At di¡er-
ent times the pH of the suspension was measured using a pH meter.
Control suspension contained no antifungal protein.
3. Results
3.1. Puri¢cation of antifungal peptide
GAFP was puri¢ed from the leaves of G. biloba. Puri¢ca-
tion of GAFP entailed the following four steps: ammonium
sulfate fractionation, a⁄nity chromatography on regenerated
chitin, FPLC on a Superose 12 column, and C18 reverse-phase
HPLC. Fractions or eluates from the second to the last steps
were assayed for growth inhibition activity against the fungus,
P. sasakii Ito. At the second step, proteins, which could bind
chitin especially, were released from chitin matrix with 20 mM
acetic acid, pH 3.3. The whole protein peak contained a
30 kDa protein and peptides. By the method of Trudel et
al. [19], the band of the 30 kDa protein in SDS^PAGE gels
was detected to have chitinase activity (data not shown). The
whole protein peak was then subjected to FPLC. A fraction
that eluted at 19 min showed strong antifungal activity. SDS^
PAGE analysis showed that this fraction only contained pep-
tides. This fraction was then subjected to C18 reverse-phase
HPLC. Two separate protein peaks were eluted (Fig. 1). The
second peak showed strong antifungal activity while very low
activity was detected in proteins of the other peak (Figs. 1 and
2). From 500 g of G. biloba leaves, approximately 4 mg of the
puri¢ed GAFP was obtained for analysis.
3.2. Amino acid sequence and mass spectrometry analysis
The amino acid sequence of 38 residues was obtained from
N-terminal sequencing (Fig. 3), thereafter the sequencer re-
sponse dropped abruptly. According to the mass spectrometry
analysis, the sequence of 38 residues must be the complete
sequence of GAFP. The molecular mass obtained from the
mass spectrometry analysis was 4244.0 Da, and the mass cal-
culated from the 38 residues determined by sequencing was
4250.7 Da, i.e. 6 Da in excess of that measured by mass
spectrometry. This di¡erence of 6 Da is attributable to the
arrangement of six cysteine residues into three intramolecular
disul¢de bridges, a process that eliminates six hydrogen
atoms. The ¢rst residue of the sequence is not methionine,
therefore GAFP is probably synthesized as part of a larger
precursor.
The amino acid sequence of GAFP contains characteristics
of the cysteine/glycine-rich chitin binding domain of many
chitin binding proteins as seen in Fig. 3. The cysteine residues
are well conserved.
3.3. Assay of antifungal activity
Antifungal activities of GAFP were tested against ¢ve phy-
topathogenic fungi. The fungi examined in this study were
P. sasakii Ito, A. alternata (Fries) Keissler, F. graminearum
Schw., F. moniliforme and P. boehmeriae. GAFP showed po-
tent antifungal activities against the agronomically important
pathogen P. sasakii Ito with as little as 100 ng of GAFP per
disk (Fig. 2). It also inhibited the growth of other plant patho-
Fig. 1. Puri¢cation of GAFP by HPLC. 1 mg amounts of the
FPLC GAFP peak were loaded on a reverse-phase C18 column
(ABI) in equilibrium with 0.1% TFA. The column was eluted at
1 ml/min with the following gradient (solvent B is acetonitrile con-
taining 0.1% TFA): 0^50 min, 0^50% B. The eluate was monitored
for protein by measurement of the absorbance at 214 nm. Chroma-
tography was performed on a HP 1090 HPLC station. The molecu-
lar mass of the active fraction was determined by 15% SDS^PAGE
(right panel). Lane M: molecular mass standards; lane G: active
fraction after C18 reverse-phase HPLC.
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gens, including A. alternata (Fries) Keissler, F. graminearum
Schw. and F. moniliforme (Fig. 2). The puri¢ed GAFP had no
e¡ect on the growth of the pathogen P. boehmeriae at 15 Wg of
GAFP per disk.
The percent growth inhibition of GAFP against P. sasakii
Ito was assayed (Fig. 4). At concentrations ranging from 0 to
10 Wg/ml GAFP did not show evident antifungal activity.
GAFP showed increased growth inhibition activity to P. sa-
sakii Ito as the concentration rose from 20 to 100 Wg/ml. Then
the activity did not rise rapidly any more.
3.4. Hyphal membrane permeabilization assay and external pH
measurements
To test the e¡ect of GAFP on permeabilization of the hy-
phal membrane, P. sasakii Ito hyphae were incubated in the
presence of [14C]leucine. After uptake of this compound, the
hyphae were washed and treated with GAFP, and then release
of [14C]leucine was measured. As shown in Fig. 4, GAFP
caused a 3^4-fold increase in the release of the amino acid
when the concentration of GAFP rose from 20 to 100 Wg/ml.
The minimal concentration required for evident growth inhi-
bition e¡ect was about 20 Wg/ml. Above the concentration
tested (100 Wg/ml), GAFP could not cause more release of
the amino acid.
When applied at 100 Wg/ml to P. sasakii Ito hyphae, GAFP
caused a rapid alkalization of the medium. The pH of the
external medium rose from 6.01 to 6.30 within 5 min. After
5 min, the pH of the external medium rose slowly from 6.30 to
6.41. At last the pH of the external medium did not rise any
more and kept at about pH 6.41.
4. Discussion
Hevein is believed to be small enough to penetrate through
the fungal cell wall and to reach the plasma membrane, where
it may have an e¡ect on active sites of cell wall morphogenesis
[9]. In this paper we found that GAFP could cause increased
hyphal membrane permeabilization, as measured by increased
[14C]leucine release from preloaded hyphae, at a concentration
of 20 Wg/ml, which is equal to the minimal concentration
required for an evident growth inhibition e¡ect. But compared
with thionine which a¡ects growth of ¢lamentous fungi
mainly by causing membrane permeabilization [20], GAFP
only caused a 3^4-fold increase in the release of the amino
acid at the concentration tested (100 Wg/ml). At this concen-
tration (100 Wg/ml), thionine could cause a 20-fold increase in
the release of the amino acid [20]. Hence, for GAFP, mem-
brane permeabilization appears to be a secondary e¡ect, but
not the primary cause of hyphal growth inhibition. When
applied at 100 Wg/ml to P. sasakii Ito hyphae, GAFP caused
a rapid alkalization of the medium within 5 min. It seems that
GAFP can cause a change in ion £ux on the fungal mem-
brane. Meanwhile, as seen in Fig. 4, the hyphal growth inhi-
bition action of GAFP corresponds to the release of the ami-
no acid. According to these data, we speculate that GAFP
exhibits its antifungal activity by interaction with the fungal
membrane.
Many proteins exist in a precursor form. The ¢rst residue of
Fig. 2. Antifungal activities in vitro of the puri¢ed GAFP against
P. sasakii Ito (A), A. alternata (Fries) Keissler (B), F. graminearum
Schw. (C), and F. moniliforme (D). Approximately 2 and 1 Wg of
the puri¢ed GAFP in 20 Wl of 10 mM sodium acetate bu¡er, pH
5.4, were applied on the disks numbered 3 and 4 respectively. For
control, 20 Wl of the water and bovine serum albumin were tested
on the disks numbered 1 and 2 respectively.
Fig. 3. Amino acid sequences of GAFP and comparison of the se-
quence with related proteins. Amino acids identical to GAFP are in-
dicated by gray boxes. HEVEIN: rubber latex hevein [21]. AMP:
two antimicrobial peptides from A. caudatus (accession number
P27275). ENDOCHITINASE 1 PRECURSOR: endochitinase 1
precursor (accession number P52403). SEED CHITINASE A: seed
chitinase A (accession number P29022). CHI4 BRANA: basic endo-
chitinase CHB4 precursor (accession number Q06209). METALLO-
THIONEIN-A: metallothionein A (accession number P04734).
Fig. 4. The e¡ect of GAFP on growth inhibition and [14C]leucine
release in P. sasakii Ito hyphae. Dose^response curves of growth in-
hibition (solid line) and [14C]leucine release (dashed line) in P. sasa-
kii Ito hyphae treated with GAFP. Values are expressed as the
means of three replicates.
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GAFP is not methionine, so we think there must exist another
large protein that contains GAFP in vivo. Some unknown
signal may cleave the large protein to produce GAFP, which
is small enough to penetrate through the fungal cell wall.
As a kind of e¡ective fungistat, GAFP showed potent anti-
fungal activities against four agronomically important patho-
gens in vitro. Moreover, its primary structure is very simple.
All this will bene¢t its application in agriculture.
References
[1] Bohlmann, H. and Apel, K. (1991) Annu. Rev. Plant Physiol.
Plant Mol. Biol. 42, 227^240.
[2] Florack, D.E.A. and Stiekema, W.J. (1994) Plant Mol. Biol. 26,
25^37.
[3] Gu, Q., Kawata, E.E., Morse, M.J., Wu, H.M. and Cheung,
A.Y. (1992) Mol. Gen. Genet. 234, 89^96.
[4] Broekaert, W.F., Terras, F.R.G., Cammue, B.P.A. and Osborn,
R.W. (1995) Plant Physiol. 108, 1353^1358.
[5] Terras, F.R.G., Schoofs, H.M.E., De Bolle, M.F.C., Van
Leuven, F., Rees, S.B., Vanderleyden, J., Cammue, B.P.A. and
Broekaert, W.F. (1992) J. Biol. Chem. 267, 15301^15309.
[6] Terras, F.R.G., Eggermont, K., Kovaleva, V., Raikhel, N.V.,
Osborn, R.W., Kester, A., Rees, S.B., Vanderleyden, J., Cam-
mue, B.P.A. and Broekaert, W.F. (1995) Plant Cell 7, 573^
588.
[7] Broekaert, W.F., Marien, W., Terras, F.R.G., De Bolle, M.F.C.,
Proost, P., Van Damme, J., Dillen, L., Claeys, M., Rees, S.B. and
Vanderleyden, J. (1992) Biochemistry 31, 4308^4314.
[8] De Bolle, M.F.C., David, K.M.N., Rees, S.B., Vanderleyden, J.,
Cammue, B.P.A. and Broekaert, W.F. (1993) Plant Mol. Biol. 22,
1187^1190.
[9] Van Parijs, J., Broekaert, W.F., Goldstein, I.J. and Peumans,
W.J. (1991) Planta 183, 258^264.
[10] Broekaert, W.F., Cammue, B.P.A., Osborn, R.W. and Rees, S.B.
(1994) International Patent Application WO 94/115.
[11] Cammue, B.P.A., De Bolle, M.F.C., Terras, F.R.G., Proost, P.,
Van Damme, J., Rees, S.B., Vanderleyden, J. and Broekaert,
W.F. (1992) J. Biol. Chem. 267, 2228^2233.
[12] Molano, J., Duran, A. and Cabib, E. (1977) Anal. Biochem. 83,
648^656.
[13] Laemmli, U.K. (1970) Nature 227, 680^685.
[14] Bradford, M.M. (1976) Anal. Biochem. 72, 248^254.
[15] Fullmer, C.S. (1984) Anal. Biochem. 142, 336^339.
[16] Roberts, W.K. and Selitrenniko¡, C.P. (1986) Biochim. Biophys.
Acta 880, 161^170.
[17] Duvick, J.P., Rood, T., Gururaj Rao, A. and Marshak, D. (1992)
J. Biol. Chem. 267, 18814^18820.
[18] Singleton, L.L., Mihail, J.D. and Rush, C.M. (1992) Methods for
Research on Soilborne Phytopathogenic Fungi, APS Press, Min-
neapolis, MN.
[19] Trudel, J. and Asselin, A. (1989) Anal. Biochem. 178, 362^366.
[20] Thevissen, K., Ghazi, A., De Samblanx, G.W., Brownlee, C.,
Osborn, R.W. and Broekaert, W.F. (1996) J. Biol. Chem. 271,
15018^15025.
[21] Broekaert, I., Lee, H.I., Kush, A., Chua, N.H. and Raikhel, N.V.
(1990) Proc. Natl. Acad. Sci. USA 87, 7633^7637.
FEBS 23953 21-7-00
X. Huang et al./FEBS Letters 478 (2000) 123^126126
